Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

3.1K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-neutralization of SARS-CoV-2 BA.3.2.2 lineage by JN.1 mRNA vaccine-induced immunity.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Phylogenetic Analyses of <i>RdRp</i> Region and <i>VP1</i> Gene in Human Norovirus Genotype GII.17[P17] Variants.

Microorganisms·2026
Same author

Decoding viral evolution through integrative bioinformatics: From genomes to global health.

Virology·2026
Same author

Phage homing endonuclease amplifies anti-defense genes to evade bacterial immunity.

Nature communications·2026
Same author

Applications of Pseudoviruses Bearing Glycoproteins of SARS-CoV-2 and Influenza Virus.

Advances in experimental medicine and biology·2026
Same author

ZO-2 determines cell membrane localization of receptor NTCP and supports hepatitis B virus infection.

mBio·2026

Related Experiment Video

Updated: Jan 8, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.6K

CD46 regulates hepatitis B virus entry by modulating cell-surface NTCP levels through cis-interaction.

Kei Miyakawa1,2,3,4, Yusuke Nakai2, Taichi Kameya5,6

  • 1AIDS Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo 208-0011, Japan.

Journal of Molecular Cell Biology
|December 23, 2025
PubMed
Summary
This summary is machine-generated.

CD46 regulates Hepatitis B virus (HBV) entry by controlling the expression of its receptor, sodium taurocholate co-transporting polypeptide (NTCP). Targeting CD46 with antibodies inhibits HBV infection.

Keywords:
hepatitis B virus (HBV)proximity-based labelingsodium taurocholate co-transporting polypeptide (NTCP)viral entry

More Related Videos

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.8K
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.9K

Related Experiment Videos

Last Updated: Jan 8, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.6K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.8K
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.9K

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis B virus (HBV) infection is a significant global health issue.
  • Sodium taurocholate co-transporting polypeptide (NTCP) is the main receptor for HBV entry, but its regulation is not fully understood.

Purpose of the Study:

  • To identify regulatory factors of NTCP-mediated HBV entry.
  • To investigate the role of CD46 in HBV infection.

Main Methods:

  • Proximity-based labeling screening to identify protein interactions.
  • Depletion of CD46 to assess its effect on NTCP levels and HBV infection.
  • Treatment with anti-CD46 monoclonal antibodies to evaluate antiviral effects.
  • Experiments conducted in hepatocytes and primary human hepatocytes.

Main Results:

  • CD46 was identified as a crucial regulator of NTCP membrane expression, interacting with NTCP in cis.
  • CD46 depletion reduced cell-surface NTCP and HBV infection.
  • Anti-CD46 antibodies inhibited HBV infection by inducing NTCP internalization.
  • Antiviral effects were confirmed in primary human hepatocytes.

Conclusions:

  • CD46 plays a key role in regulating NTCP-mediated HBV entry.
  • CD46 represents a potential therapeutic target for treating Hepatitis B infection.